Last reviewed · How we verify

NCT04783948

Validity and Reliability of the Turkish Version of the Pectus Carinatum Evaluation Questionnaire for Patients With Pectus Carinatum

Completed Last updated 22 October 2021
What this trial tests

trial testing Brace Treatment in Pectus Carinatum in 60 participants. Completed in 18 October 2021.

Timeline
3 March 2021
Primary endpoint
3 May 2021
18 October 2021

Quick facts

Lead sponsorAcibadem University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment60
Start date3 March 2021
Primary completion3 May 2021
Estimated completion18 October 2021
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Acibadem University

Who can join

Adults 10 to 18, any sex, with Pectus Carinatum or Compliance. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Based on the hypothesis that the chest wall was still pliable in adolescence and could be reshaped in a normal position with the external suppressor applied on the chest, a pressure orthosis was started to be used in the pectus carinatum. It is the focus of attention as it is an alternative method to surgery for patients. However, the patient's compliance with the orthosis is difficult. Therefore, in our study, we aimed to investigate the Turkish Validity and Reliability of the Pectus Carinatum Evaluation Questionnaire, which is a questionnaire investigating the compliance with orthosis treatment in patients diagnosed with Pectus Carinatum by the doctor.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Brace Treatment

Trials testing the same drug.

Other Acibadem University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04783948.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing